Chenodeoxycholic Acid Market – Bile Acid Therapies for Liver and Metabolic Disorders
The chenodeoxycholic acid (CDCA) market focuses on this naturally occurring bile acid used therapeutically for liver diseases, cholesterol metabolism regulation, gallstone dissolution, and clinical research. As understanding of bile acid signaling grows, CDCA is gaining attention for metabolic and hepatobiliary indications. The market was valued at around USD 500 million in 2024, expected to...
0 Комментарии 0 Поделились 18 Просмотры 0 предпросмотр